Home › Funds › Vestal Point Capital, LP › TECX

Vestal Point Capital, LP position in TECX

TECTONIC THERAPEUTIC INC · Health Care

Vestal Point Capital, LP reported holding 425,000 shares of TECX (TECTONIC THERAPEUTIC INC) in its Q2 2026 13F filing — a position valued at US$14.6M, representing 0.34% of its reported portfolio and ranking #49 among its reported holdings. Vestal Point Capital, LP has disclosed TECX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)425.00K sh
Reported value held$14.61M
Portfolio Weight0.34%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's TECX position evolved

Vestal Point Capital, LP first disclosed a stake in TECX in Q4 2025 at 328,000 shares (US$6.8M). The position peaked in Q2 2026 at 425,000 shares, worth US$14.6M. Across 3 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 425,000 shares valued at US$14.6M — an increase of 97,000 shares quarter over quarter.. Notable position changes include a 30% increase in Q2 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 328.00K $6.84M New
Q1 2026 328.00K $10.14M Hold
Q2 2026 425.00K $14.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECX and 13F data

TECX (TECTONIC THERAPEUTIC INC) is a Health Care company. 54 other funds we track also report a position in TECX — the largest reported positions include TCG Crossover Management, LLC (US$41.4M), First Light Asset Management, LLC (US$27.5M), 5AM Venture Management, LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECX

All TECX fund holders →

FAQ

How long has Vestal Point Capital, LP held TECX?

Vestal Point Capital, LP has disclosed TECX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Vestal Point Capital, LP's current position in TECX?

As of Q2 2026, Vestal Point Capital, LP holds 425.00K shares of TECX (TECTONIC THERAPEUTIC INC), valued at $14.61M, representing 0.34% of its reported portfolio and ranking #49.

Has Vestal Point Capital, LP been buying or selling TECX?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in TECX. The position peaked in Q2 2026 at 425.00K shares.

Which other funds hold TECX?

Other major institutional holders of TECX include TCG Crossover Management, LLC, First Light Asset Management, LLC, 5AM Venture Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.